| PEMOA34 | Seroprevalence of cross-reactive anti-SARS-CoV-2 antibodies in pre-COVID-19 samples collected from Cameroonian women during pregnancy and at delivery | Poster exhibition | Immune responses to SARS-Cov2 |
| PESUA23 | Longer intervals between SARS-CoV-2 infection and SpikeVax doses improve the neutralization of different variants of concern | Poster exhibition | Immune responses to SARS-Cov2 |
| PESUA25 | Unvaccinated individuals admitted to the ICU due to fatal COVID-19 showed progressive decay of unresponsive cytotoxic cells | Poster exhibition | Immune responses to SARS-Cov2 |
| EPA038 | Genetic polymorphism of toll-like receptors (TLRs) in HIV-I infected patients with and without tuberculosis (TB) co-infection | E-poster | Immune mechanisms of natural or post-treatment control |
| EPA039 | Spontaneous HIV control is associated with concentrations, and not the biophysical characteristics, of polyfunctional anti-Env specific antibody responses | E-poster | Immune mechanisms of natural or post-treatment control |
| EPA040 | Investigating mechanisms of antigen-independent CD8+ T cell enforcement of HIV latency | E-poster | Immune mechanisms of natural or post-treatment control |
| OAA0205 | Exceptional post-treatment control associated with strong NK and Ï?É? cytotoxic T cells | Oral abstract session with live Q&A | Immune mechanisms of natural or post-treatment control |
| EPA050 | Tissues as tools in HIV-1 cure research | E-poster | Identification, characterisation and Quantification of HIV/SIV reservoirs and rebounding virus |
| EPA051 | A new in-vitro model to monitor HIV-1 proviral transcription by Timer-fluorescence protein | E-poster | Identification, characterisation and Quantification of HIV/SIV reservoirs and rebounding virus |
| EPA052 | HIV genetic diversity and compartmentalization in lung and blood of individuals onlong-term ART | E-poster | Identification, characterisation and Quantification of HIV/SIV reservoirs and rebounding virus |